β-thalassemia IVS-II-654(C>T)&IVS-II-654(C>T) double mutation Reference Standard
CBPD0007
詢 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Mutation 1 | Variation site: CD71-72(+A) |
| DNA Change: c.216_217insA | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5247905_5247906 insA | |
| Transcript: NM_000518.5 | |
| Mutation 2 | Variation site: IVS-II-654(C>T) |
| DNA Change: c.316-197C>T | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5247153C>T | |
| Transcript: NM_000518.5 | |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 2-8℃ |
| Expiry | 36 months from the date of manufacture |
